FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2417707485> ?p ?o ?g. }

• W2417707485 abstract "Background The development of direct acting antiviral agents (DAAs) represents a significant improvement in hepatitis C virus (HCV) treatment. Interferon free combinations such as sofosbuvir (SOF) plus daclatasvir (DAC) have become available this year but at a high economic cost, and it is necessary to assess this with real life data. Purpose To evaluate the short term efficacy and safety of SOF plus DAC for the treatment of HCV monoinfected patients. Material and methods Observational study of patients who initiated therapy with SOF plus DAC between February and June 2015. Data were collected from electronic clinical history and the hospital’s electronic prescribing software. The following variables were collected: sex, HCV genotype, liver fibrosis stage, type of patient (pretreated/treatment naive), treatment duration, RNA viral levels before starting treatment, and 4 and 12 weeks afterwards. Monitoring of treatment efficacy was based on repeated measurements of HCV RNA levels. Results 27 patients started treatment, 20 men and 7 women, 10 with ribavirin. Regarding type of patient, 4 were treatment naive, 15 pretreated and 8 unknown. Genotypes 1a, 1b and 3 corresponded to 12, 7 and 7 patients, respectively. Hepatic fibrosis stage F4/F3/F2 corresponded to 13, 8 and 6 patients, respectively. Duration of treatment was: 12 weeks for 23 patients and 24 weeks for 4 patients. 59.3% of patients achieved an undetectable viral load after 4 weeks, 37% had a viral load between 15 and 100 copies/mL and 3.7% had 194 copies/mL but continued treatment. After 12 weeks, 96.3% of patients achieved undetectable viral load and 100% after 24 weeks. Only 2 patients discontinued treatment, 1 for acute kidney injury and the other for liver transplantation. 44.45% of patients reported at least one side effects. Adverse events recorded were: asthenia (14.8%), insomnia (11.1%), headache (7.4%) and pruritus (3.7%). Conclusion More than 50% of patients treated with the SOF-DAC combination had an undetectable level of HCV-RNA after 4 weeks and almost 100% after 12 weeks but these results are still preliminary; it is necessary to determine the sustained virological response to evaluate treatment efficacy. Regarding safety, the main adverse effect was asthenia but in general SOF-DAC was well tolerated. No conflict of interest." @default.
• W2417707485 created "2016-06-24" @default.
• W2417707485 creator A5018763283 @default.
• W2417707485 creator A5028591812 @default.
• W2417707485 creator A5037393286 @default.
• W2417707485 creator A5075718106 @default.
• W2417707485 creator A5084087889 @default.
• W2417707485 creator A5091734916 @default.
• W2417707485 date "2016-02-14" @default.
• W2417707485 modified "2023-09-27" @default.
• W2417707485 title "CP-033 Evaluation of sofosbuvir plus daclatasvir combination for hepatitis C virus treatment" @default.
• W2417707485 doi "https://doi.org/10.1136/ejhpharm-2016-000875.33" @default.
• W2417707485 hasPublicationYear "2016" @default.
• W2417707485 type Work @default.
• W2417707485 sameAs 2417707485 @default.
• W2417707485 citedByCount "0" @default.
• W2417707485 crossrefType "journal-article" @default.
• W2417707485 hasAuthorship W2417707485A5018763283 @default.
• W2417707485 hasAuthorship W2417707485A5028591812 @default.
• W2417707485 hasAuthorship W2417707485A5037393286 @default.
• W2417707485 hasAuthorship W2417707485A5075718106 @default.
• W2417707485 hasAuthorship W2417707485A5084087889 @default.
• W2417707485 hasAuthorship W2417707485A5091734916 @default.
• W2417707485 hasConcept C126322002 @default.
• W2417707485 hasConcept C142462285 @default.
• W2417707485 hasConcept C159047783 @default.
• W2417707485 hasConcept C2522874641 @default.
• W2417707485 hasConcept C2776178377 @default.
• W2417707485 hasConcept C2776408679 @default.
• W2417707485 hasConcept C2776455275 @default.
• W2417707485 hasConcept C2776979040 @default.
• W2417707485 hasConcept C2778390639 @default.
• W2417707485 hasConcept C2780040827 @default.
• W2417707485 hasConcept C71924100 @default.
• W2417707485 hasConcept C90924648 @default.
• W2417707485 hasConceptScore W2417707485C126322002 @default.
• W2417707485 hasConceptScore W2417707485C142462285 @default.
• W2417707485 hasConceptScore W2417707485C159047783 @default.
• W2417707485 hasConceptScore W2417707485C2522874641 @default.
• W2417707485 hasConceptScore W2417707485C2776178377 @default.
• W2417707485 hasConceptScore W2417707485C2776408679 @default.
• W2417707485 hasConceptScore W2417707485C2776455275 @default.
• W2417707485 hasConceptScore W2417707485C2776979040 @default.
• W2417707485 hasConceptScore W2417707485C2778390639 @default.
• W2417707485 hasConceptScore W2417707485C2780040827 @default.
• W2417707485 hasConceptScore W2417707485C71924100 @default.
• W2417707485 hasConceptScore W2417707485C90924648 @default.
• W2417707485 hasLocation W24177074851 @default.
• W2417707485 hasOpenAccess W2417707485 @default.
• W2417707485 hasPrimaryLocation W24177074851 @default.
• W2417707485 hasRelatedWork W2282418649 @default.
• W2417707485 hasRelatedWork W2409643477 @default.
• W2417707485 hasRelatedWork W2413411444 @default.
• W2417707485 hasRelatedWork W2416931831 @default.
• W2417707485 hasRelatedWork W2417848318 @default.
• W2417707485 hasRelatedWork W2546358667 @default.
• W2417707485 hasRelatedWork W2608263244 @default.
• W2417707485 hasRelatedWork W2618178191 @default.
• W2417707485 hasRelatedWork W2618945960 @default.
• W2417707485 hasRelatedWork W2711908194 @default.
• W2417707485 hasRelatedWork W2774813701 @default.
• W2417707485 hasRelatedWork W2804388837 @default.
• W2417707485 hasRelatedWork W2885623036 @default.
• W2417707485 hasRelatedWork W2921181526 @default.
• W2417707485 hasRelatedWork W2966816729 @default.
• W2417707485 hasRelatedWork W2972099396 @default.
• W2417707485 hasRelatedWork W3003489580 @default.
• W2417707485 hasRelatedWork W3029304853 @default.
• W2417707485 hasRelatedWork W3094295802 @default.
• W2417707485 hasRelatedWork W3164297270 @default.
• W2417707485 isParatext "false" @default.
• W2417707485 isRetracted "false" @default.
• W2417707485 magId "2417707485" @default.
• W2417707485 workType "article" @default.